Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.006 EUR | 0.00% | 0.00% | -40.00% |
2021 | Ovoca Bio : Enrolls First Patient in Phase 2 Trial for Hypoactive Sexual Desire Disorder Treatment | MT |
Sales 2021 | - | Sales 2022 | - | Capitalization | 4.89M 4.58M 408M |
---|---|---|---|---|---|
Net income 2021 | -5M -4.68M -417M | Net income 2022 | -5M -4.68M -417M | EV / Sales 2021 | - |
Net cash position 2021 | 6.59M 6.17M 550M | Net cash position 2022 | 3.7M 3.46M 309M | EV / Sales 2022 | - |
P/E ratio 2021 |
-2.23
x | P/E ratio 2022 |
-0.87
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 47.54% |
Current month | +20.00% | ||
1 month | +20.00% | ||
3 months | -40.00% | ||
6 months | -60.00% | ||
Current year | -40.00% |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 0.006 | 0.00% | 0 |
25/24/25 | 0.006 | 0.00% | 0 |
24/24/24 | 0.006 | 0.00% | 30,000 |
23/24/23 | 0.006 | 0.00% | 0 |
22/24/22 | 0.006 | 0.00% | 0 |
Real-time Irish S.E., April 26, 2024 at 09:25 pm IST
More quotes1st Jan change | Capi. | |
---|---|---|
-40.00% | 522K | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- OVXA Stock